Healthcare Trending Market Reports

Patient Access Solutions Market Size, Share, key Trends, Top Leaders and Analyzed information by Global Patient Access Solutions Market – Service (Support & Maintenance and Implementation), Software (Eligibility Verification Software and Medical Necessity Management Software,), End User & Region—Global Forecast till 2024 Patient access solutions can be used by patients to gain access to their records, prescriptions, reports, and bills in a centralized location. The software helps in identification, management, and collection of data. The global patient access solutions market report by Market Research Future (MRFR) uses industry insights accumulated from experts by analysts for the compilation of pertinent drivers and challenges in a comprehensive manner. Market Overview The global patient access solutions market is predicted to accrue revenues at a CAGR of 7.5% during the forecast period ( 2019-2024 ). The market can thrive by minimizing the amount of staff required for mana

The global cancer registry software market is expected to grow significantly over the forecast period. The market held a market value of USD 56.4 million in 2018 and is projected to grow at a CAGR of 10.7% over the forecast period. Increasing prevalence of cancer, favorable government initiatives, rising pressure to improve the quality of care and reduce healthcare costs, rising adoption of EHRs, and the growing use of cancer patient registry data for post-marketing surveillance are positively affecting market growth. Segmentation By type, the market has been segmented into integrated software and standalone software. Based on the deployment model, the market has been segmented into cloud-based models and on-premise models. On the basis of the database type, the market has been segmented into commercial databases and public databases. By functionality, the market has been segmented into patient care management, product outcome evaluation, cancer reporting to meet state and federal regu

Market Key Players Teva Pharmaceutical Industries Ltd. (Israel), Becton, Dickinson and Company (U.S.) Corvida Medical (U.S.) ICU Medical Inc. (U.S.) Yukon Medical (U.S.) Equashield LLC (U.S.) The global closed system drug transfer device (CSTD) market size is poised to expand at 19.10% CAGR over the forecast period (2018–2025). The market is driven by the prevalence of cancer cases globally. According to the Canadian Cancer Society in 2017, nearly 206, 200 instances were registered with 80,800 dying from the disease. CSTDs are required for protecting hospital staff from hazardous drugs and ensuring their safety. Furthermore, safety guidelines outlined by regulatory bodies for safe handling practices at hospitals and clinics is predicted to augur well for the closed system drug transfer device market share Segmentation Analysis The closed system drug transfer device (CSTD) market is segmented by type, delivery, and end-user. By type, barrier-type was the largest shareholder in 2017, whi

The global cancer registry software market is expected to grow significantly over the forecast period. The market held a market value of USD 56.4 million in 2018 and is projected to grow at a CAGR of 10.7% over the forecast period. Increasing prevalence of cancer, favorable government initiatives, rising pressure to improve the quality of care and reduce healthcare costs, rising adoption of EHRs, and the growing use of cancer patient registry data for post-marketing surveillance are positively affecting market growth. Segmentation By type, the market has been segmented into integrated software and standalone software. Based on the deployment model, the market has been segmented into cloud-based models and on-premise models. On the basis of the database type, the market has been segmented into commercial databases and public databases. By functionality, the market has been segmented into patient care management, product outcome evaluation, cancer reporting to meet state and federal regu

Market Research Future published a research report on Craniomaxillofacial (CMF) Devices Market Research Report - Global Forecast till 2024. Report gives a clear picture of current market scenario which includes past and estimated future market size The increasing participation of key players is one of the key factors driving the craniomaxillofacial devices market. In 2019, Kelyniam Global (KLYG) received premarket FDA approval for unique modifications to their PEEK cranio-maxillofacial implant product line. Regional Analysis In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region. The CMF devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European CMF devices market has been segmented into Western Europe and Eastern Europe. Western Europe has be

Market Research Future (MRFR) publishes periodic market research reports Nuclear Imaging Devices Market Research Report - Global Forecast till 2024 on niche and emerging technologies. The increasing prevalence of cardiovascular disorders is one of the key factors driving the nuclear imaging devices market. As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease. Segmentation The global nuclear imaging devices market is segmented based on technology, application, end user, and region. The global market for nuclear imaging devices, by technology, is segmented into positron emission tomography (PET), single photon emission computed tomography (SPECT), and planar scintigraphy. The single-photon-emission computed tomography (SPECT) are further classified as hybrid SPECT systems and standalone SPECT systems. Based on application, the market is segmented into oncology,